全球醫學微生物檢測技術市場

到 2030 年，全球醫學微生物檢測技術市場規模將達到 37 億美元

全球醫學微生物檢測技術市場規模預計在2024年為29億美元，預計到2030年將達到37億美元，在分析期內（2024-2030年）的複合年成長率為4.1%。呼吸系統疾病是本報告分析的細分市場之一，預計其複合年成長率為4.9%，到分析期結束時規模將達到14億美元。神經系統疾病細分市場在分析期間的複合年成長率預計為3.6%。

美國市場規模估計為 7.471 億美元，中國市場預計複合年成長率為 7.1%

美國醫學微生物檢測技術市場規模預計2024年達到7.471億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到8.647億美元，在2024-2030年的分析期內，複合年成長率為7.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.3%和3.1%。在歐洲，預計德國市場的複合年成長率為2.1%。

全球醫學微生物學檢測技術市場—主要趨勢與促進因素摘要

為什麼醫學微生物學檢測對醫療保健至關重要？

醫學微生物檢測技術對於識別傳染源、確定治療方案和預防疾病爆發至關重要。這些技術用於診斷細菌、病毒和真菌感染，對管理從呼吸道感染到醫院內感染等一系列疾病至關重要。隨著人們對抗生素抗藥性和新興感染疾病的擔憂日益加劇，快速、準確的微生物檢測已成為醫療保健領域的首要任務。醫學微生物檢測在減少疾病傳播和支持公共衛生舉措方面發揮著重要作用。

哪些創新推動了醫學微生物學檢測？

分子診斷、聚合酵素鏈鎖反應(PCR) 技術和自動化檢測平台的技術進步徹底改變了醫學微生物學。分子診斷技術能夠在基因層面快速檢測病原體，與傳統培養方法相比，數小時內即可提供結果。即時PCRPCR 等 PCR 技術的發展提高了檢測的靈敏度和準確性，從而能夠更早地進行診斷並進行針對性治療。自動化檢測平台和實驗室晶片技術簡化了檢測流程，縮短了周轉時間並增加了檢測量。這些創新使微生物檢測速度更快、更準確，也更容易在醫療機構中普及。

醫療保健領域的哪些領域正在引領微生物學檢測技術的使用？

醫院實驗室、公共衛生部門和門診對先進微生物檢測的需求最高。醫院實驗室使用微生物檢測進行感染疾病診斷、抗生素指導和感染控制。公共衛生機構利用這些技術追蹤感染疾病疫情，並提供公共衛生應對所需的關鍵數據。門診受益於常見感染疾病的快速診斷工具，從而能夠更快地進行治療。微生物檢測在醫療保健領域的廣泛應用凸顯了其在維護公共衛生和病人安全方面發揮的關鍵作用。

醫學微生物學檢測市場的成長受到多種因素的推動

醫學微生物檢測技術市場的成長受到多種因素的推動，包括感染疾病疫情的上升、分子診斷技術的進步以及人們對抗生素抗藥性認知的不斷提高。全球範圍內感染疾病的增加推動了對快速精準檢測解決方案的需求。技術進步，尤其是PCR和自動化技術，提高了診斷的準確性和速度，使其成為醫療保健提供者不可或缺的技術。此外，旨在對抗抗生素抗藥性的公共衛生舉措凸顯了微生物檢測的重要性，從而推動了市場成長，並促進了先進診斷技術的普及。

部分

用途（診斷、治療監測）；最終用途（醫院實驗室、病理實驗室、研究實驗室）；適應症（呼吸系統疾病、神經系統疾病、感染疾病）

受訪公司範例（41家值得關注的公司）

• Abbott Laboratories
• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Himedia Laboratories
• Hologic, Inc.
• Thermo Fisher Scientific, Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Medical Microbiology Testing Technologies Market to Reach US$3.7 Billion by 2030

The global market for Medical Microbiology Testing Technologies estimated at US$2.9 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Respiratory Diseases, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Neurological Diseases segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$747.1 Million While China is Forecast to Grow at 7.1% CAGR

The Medical Microbiology Testing Technologies market in the U.S. is estimated at US$747.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$864.7 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Medical Microbiology Testing Technologies Market - Key Trends & Drivers Summarized

Why Are Medical Microbiology Testing Technologies Vital in Healthcare?

Medical microbiology testing technologies are crucial for identifying infectious agents, guiding treatment decisions, and preventing disease outbreaks. These technologies are used to diagnose bacterial, viral, and fungal infections, essential for managing conditions ranging from respiratory infections to hospital-acquired infections. With rising concerns over antibiotic resistance and emerging infectious diseases, rapid and accurate microbiology testing has become a top priority in healthcare. Medical microbiology testing plays a fundamental role in reducing disease transmission and supporting public health initiatives.

What Innovations Are Driving Medical Microbiology Testing?

Technological advancements in molecular diagnostics, polymerase chain reaction (PCR) technology, and automated testing platforms have revolutionized medical microbiology. Molecular diagnostics enable rapid detection of pathogens at a genetic level, providing results within hours compared to traditional culture methods. PCR advancements, such as real-time PCR, enhance test sensitivity and accuracy, allowing for earlier diagnosis and targeted treatment. Automated testing platforms and lab-on-a-chip technologies have streamlined testing processes, enabling faster turnaround times and higher testing volumes. These innovations have made microbiology testing faster, more precise, and accessible across healthcare facilities.

Which Medical Sectors Are Leading the Use of Microbiology Testing Technologies?

The demand for advanced microbiology testing is highest in hospital laboratories, public health departments, and outpatient clinics. Hospital laboratories rely on microbiology testing for diagnosing infections, guiding antibiotic use, and managing infection control. Public health agencies use these technologies to track infectious disease outbreaks, providing essential data for public health responses. Outpatient clinics benefit from rapid diagnostic tools for common infections, allowing for prompt treatment. This widespread adoption across healthcare settings highlights the critical role of microbiology testing in maintaining public health and patient safety.

The Growth in the Medical Microbiology Testing Technologies Market Is Driven by Several Factors

The growth in the medical microbiology testing technologies market is driven by several factors, including the rise in infectious disease prevalence, advancements in molecular diagnostics, and increasing awareness of antibiotic resistance. The global increase in infectious diseases has heightened demand for fast, accurate testing solutions. Technological advancements, especially in PCR and automation, have enhanced diagnostic accuracy and speed, making these technologies indispensable for healthcare providers. Furthermore, public health initiatives aimed at combating antibiotic resistance have underscored the importance of microbiology testing, driving market growth and supporting the adoption of advanced diagnostic technologies.

SCOPE OF STUDY:

The report analyzes the Medical Microbiology Testing Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Diagnostic, Treatment Monitoring); End-Use (Hospital Labs, Pathology Labs, Research Institutes); Indication (Respiratory Diseases, Neurological Diseases, Infectious Diseases)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Abbott Laboratories
• Agilent Technologies, Inc.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Himedia Laboratories
• Hologic, Inc.
• Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Tariff Impact on Global Supply Chain Patterns
  • Medical Microbiology Testing Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rapid Advances in Molecular Diagnostic Technologies for Faster and More Accurate Pathogen Detection
  • Growing Demand for Point-of-Care Microbiology Testing to Improve Turnaround Time in Clinical Settings
  • Expansion of Automated High-Throughput Microbiology Testing Platforms to Enhance Laboratory Efficiency
  • Increasing Preference for Real-Time PCR and Other Rapid Diagnostic Tests for Early Infection Control
  • Rising Focus on Pathogen-Specific Detection Technologies to Address Antimicrobial Resistance Challenges
  • Adoption of Lab-on-a-Chip and Biosensor Technologies for Portable and Cost-Effective Microbial Diagnostics
  • Growing Integration of Artificial Intelligence in Microbiology Testing for Predictive Analytics and Risk Assessment
  • Rising Demand for Microbiome Analysis in Personalized Treatment Plans for Infection-Related Disorders
  • Expansion of Home-Based and Remote Microbiology Testing Solutions to Broaden Access to Diagnostics
  • Increasing Use of Biomarker and Genomic Sequencing-Based Diagnostics for Precision Pathogen Detection
  • Growth in Public Health Initiatives to Expand Microbial Testing for Surveillance and Outbreak Control
  • Rising Investment in High-Sensitivity and Multiplex Microbiology Testing for Comprehensive Diagnostics
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Medical Microbiology Testing Technologies Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Medical Microbiology Testing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Respiratory Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Neurological Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Neurological Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Neurological Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Treatment Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Treatment Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Treatment Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospital Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospital Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pathology Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pathology Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Pathology Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• JAPAN
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• CHINA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• EUROPE
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Medical Microbiology Testing Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• FRANCE
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• GERMANY
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• INDIA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
• AFRICA
  • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION